drugset / Trial / NCT03373591
Liposomal Bupivacaine in Bariatric Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of this study is to perform a randomized controlled trial for patients undergoing bariatric surgery, comparing the need for opiates with and without administration of a transversus abdominis plane (TAP) block using the long acting local anesthetic, liposomal bupivacaine (Exparel®). From this study, the investigators will assess whether use of long acting local anesthetic can reduce the need for opiates in the bariatric population.
Timeline
- Start
- 2018-01-30
- Primary completion
- 2018-06-30
- Completion
- 2018-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 20 ml | Other |
| Comparator | Bupivacaine | Other / unclassified | 50 ml | Other |
Indications
No indication recorded.